Terbinafine Clinical Trials

2 actively recruiting trials

No change since May 2026

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

Swiss Cancer Institute1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1

Indications

Liver Disease1
Chronic Hepatitis b1
Recurrent Prostate Cancer1
Cancer1

Other2 trials

From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients

Phase 1/2

Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.